Trial Profile
Effects of GSK 1521498 on neural and behavioural responses in obese patients with moderate binge eating
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Jul 2023
Price :
$35
*
At a glance
- Drugs GSK 1521498 (Primary)
- Indications Obesity
- Focus Pharmacodynamics
- 10 Nov 2013 New trial record